Prime Medicine, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2024 | $-67.7M | $-70.0M | $2.3M | $5.2M |
| Jun 2024 | $-45.5M | $-47.4M | $1.9M | — |
| Sep 2024 | $-25.9M | $-27.2M | $1.3M | — |
| Mar 2025 | $-48.9M | $-51.3M | $2.4M | $5.7M |
| Jun 2025 | $-41.4M | $-43.0M | $1.6M | — |
| Sep 2025 | $-35.0M | $-35.3M | $247.0K | — |
| Mar 2026 | $-42.7M | $-42.9M | $214.0K | $4.6M |
| Jun 2026 | $-41.0M | $-41.1M | $46.0K | — |